Literature DB >> 8464341

Vascular smooth muscle and nitric oxide.

M Zehetgruber1, A Conforto, R J Bing.   

Abstract

Experiments were performed to investigate the production of endothelium-derived relaxing factor (EDRF or nitric oxide; NO) by vascular smooth muscle cells. The lumen of bovine pulmonary arteries were filled with Krebs-Henseleit solution (incubates). Both endothelium-intact and endothelium-deprived vessels were used. Incubate solutions from the lumen of generator vessels contained a significant amount of nitric oxide (NO). Although the NO concentration was higher in incubates from endothelium-intact vessels, endothelium-deprived vessels also produced NO. The length of incubation did not influence the amount of nitric oxide released. Endothelium-deprived pulmonary arteries also generated NO as detected by chemiluminescence. The amount produced however was not sufficient to relax endothelium-deprived detector vessels in superfusion bioassay experiments. Samples from Krebs-Henseleit (K-H) solution surrounding the preparation (bathing solution) contained NO values which were also significantly higher than the control. Nitric oxide found in the bathing solution also appeared to originate from endothelium and vascular smooth muscle. Oxyhemoglobin attenuated NO signals. The results demonstrate that nitric oxide is released by vascular smooth muscle cells as well as by endothelium. However, the amount of NO released by muscle is insufficient to relax endothelium-deprived vascular preparations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464341     DOI: 10.1016/0024-3205(93)90063-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Unconventional eNOS in pulmonary artery smooth muscles: why should it be there?

Authors:  Tong Mook Kang
Journal:  Pflugers Arch       Date:  2019-09-05       Impact factor: 3.657

Review 2.  Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension.

Authors:  Sevda Gheibi; Sajad Jeddi; Khosrow Kashfi; Asghar Ghasemi
Journal:  Biochem Pharmacol       Date:  2018-01-09       Impact factor: 5.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.